Volume 13, Issue 2 pp. 180-184

Loss to follow-up of patients with malignant lymphoma

S. BROWN

S. BROWN

Department of Oncology, King Faisal Specialist Hospital and Research Center (KFSHRC), Riyadh

Search for more papers by this author
A. BELGAUMI

A. BELGAUMI

Department of Pediatric Hematology/Oncology, KFSHRC, Riyadh

Search for more papers by this author
D. AJARIM

D. AJARIM

Department of Oncology, KFSHRC, Riyadh

Search for more papers by this author
A. KOFIDE

A. KOFIDE

Department of Pediatric Hematology/Oncology, KFSHRC, Riyadh

Search for more papers by this author
R. AL SAAD

R. AL SAAD

Department of Oncology, King Faisal Specialist Hospital and Research Center (KFSHRC), Riyadh

Search for more papers by this author
R. SABBAH

R. SABBAH

Department of Pediatric Hematology/Oncology, KFSHRC, Riyadh

Search for more papers by this author
A. EZZAT

A. EZZAT

Department of Oncology, King Faisal Specialist Hospital and Research Center (KFSHRC), Riyadh

Search for more papers by this author
M. SHOUKRI

M. SHOUKRI

Department of Biostatistics, Epidemiology and Scientific Computing, KFSHRC, Riyadh, Saudi Arabia

Search for more papers by this author
R. BARR

R. BARR

Department of Pediatrics, McMaster University, Hamilton, Ontario, Canada

Search for more papers by this author
A. LEVIN

Corresponding Author

A. LEVIN

Department of Virology, St Bartholomew's Hospital School of Medicine, London, UK

Dr Arthur Levin, East Africa Research Project, 38 Little Britain, West Smithfield, London EC1A 7BE, UK (e-mail: [email protected]).Search for more papers by this author
First published: 29 April 2004
Citations: 6

Abstract

Loss to follow-up (LTFU) in cancer patients is a serious problem, yet there is little data on this and on the underlying reasons. Of 144 paediatric and 431 adult patients with lymphoma diagnosed in 1997/1998 at King Faisal Specialist Hospital and Research Center, Riyadh (KFSHRC), 30% and 48.5%, respectively, were LTFU after 4 years (excluding patients known to have died). In 2001–2002, 196 paediatric and adult lymphoma patients at KFSHRC were enrolled in a prospective study in which explanations were obtained in detail for non-attendance at follow-up appointments (No Show). Sixteen months after commencement of the study, 49 patients were No Show, because of patient-based communication problems (20), transportation problems (8), patient not contactable (18), and personal reasons (3). In addition, patients were recorded incorrectly as No Show through hospital/patient communication problems. The No Show patients, especially the 23 who failed to keep a second appointment, are identifiable as potential LTFU during the 3 years in which this cohort will be followed. This study and, we suggest, other studies on LTFU should stimulate interest in this issue, in the predisposing factors, and in strategies to address them.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.